Profile of adult patients hospitalized with COVID-19 before and after introduction of SARS-CoV-2 vaccinesPerfil de pacientes adultos hospitalizados por COVID-19 antes y después de la introducción de las vacunas contra SARS-CoV-2
| dc.article.number | em2357 | |
| dc.contributor.author | Potin M. | |
| dc.contributor.author | Aljaro S. | |
| dc.contributor.author | Lopez S. | |
| dc.contributor.author | Uauy O. | |
| dc.contributor.author | Cifuentes C. | |
| dc.contributor.author | Cerda J. | |
| dc.contributor.author | Valenzuela D. | |
| dc.contributor.other | CEDEUS (Chile) | |
| dc.date.accessioned | 2025-05-01T10:33:23Z | |
| dc.date.available | 2025-05-01T10:33:23Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | © 2023, Sociedad Chilena de Infectologia. All rights reserved.Background: During the COVID-19 pandemic, the early prioriti-zation of SARS-CoV-2 vaccines for older adults may have affected the characteristics of hospitalized COVID-19 patients over time. Aim: To compare the clinical characteristics and outcomes of adult patients admitted for COVID-19 before (PER1) and after (PER2) the initiation of mass vaccination for SARS-CoV-2. Methods: Data on age, gender, comorbidities, complications, and outcomes of adult patients hospitalized for COVID-19 in a private clinic of Santiago, Chile, were collected. Scores for COVID-19 severity and nutritional risk were calculated. Results: In PER2, patients were younger but had similar comorbidities, except for a higher prevalence of overweight and obesity compared to PER1. Unvaccinated COVID-19 patients in PER2 required more invasive ventilatory support (38.9% vs. 14.3%, p = 0.03) and had a higher severity score (six) than vaccinated patients (five, p = 0.048). The variables that best predicted mortality were age ≥ 60 years (OR 28,995) and the presence of nutritional risk (OR 5,246). Discussion: Changes in the profile and outcomes of hospitalized patients during the COVID-19 pandemic are associated with the prioritization of SARS-CoV-2 vaccines and their protective effect in reducing hospitalizations and disease severity in older adults. | |
| dc.description.funder | Chilean National Fund for Scientific and Technological Development Fondecyt, Iniciacion Grant | |
| dc.format.extent | 18 páginas | |
| dc.fuente.origen | Scopus | |
| dc.identifier.doi | 10.4067/s0716-10182023000500472 | |
| dc.identifier.eisbn | 9780128194706 | |
| dc.identifier.eissn | 1422-0067 | |
| dc.identifier.isbn | 9783031764011 | |
| dc.identifier.issn | 07161018 | |
| dc.identifier.pubmedid | 40156360 | |
| dc.identifier.scieloid | S0718-69242020000300109 | |
| dc.identifier.scopusid | SCOPUS_ID:85178894290 | |
| dc.identifier.uri | https://doi.org/10.4067/s0716-10182023000500472 | |
| dc.identifier.uri | https://repositorio.uc.cl/handle/11534/103997 | |
| dc.identifier.wosid | WOS:001126163600007 | |
| dc.information.autoruc | Escuela de Medicina; Potin Santander Marcela Patricia; 0000-0003-4985-4579; 64027 | |
| dc.information.autoruc | Escuela de Medicina; Cerda Lorca Jaime Rodrigo; 0000-0003-3463-8304; 3935 | |
| dc.information.autoruc | Escuela de Medicina; Valenzuela Suarez Andres Daniel; S/I; 163741 | |
| dc.issue.numero | 21 | |
| dc.language.iso | es | |
| dc.nota.acceso | Contenido parcial | |
| dc.pagina.final | 480 | |
| dc.pagina.inicio | 472 | |
| dc.publisher | Springer | |
| dc.relation.ispartof | Intersections Interdisciplinary Research on Architecture, Design, City and Territory | |
| dc.revista | Revista Chilena de Infectologia | |
| dc.rights | acceso restringido | |
| dc.subject | adults | |
| dc.subject | comorbidities | |
| dc.subject | COVID-19 vaccines | |
| dc.subject | mortality | |
| dc.subject | nutritional risk score | |
| dc.subject.ddc | 610 | |
| dc.subject.dewey | Medicina y salud | es_ES |
| dc.subject.ods | 03 Good health and well-being | |
| dc.subject.odspa | 03 Salud y bienestar | |
| dc.title | Profile of adult patients hospitalized with COVID-19 before and after introduction of SARS-CoV-2 vaccinesPerfil de pacientes adultos hospitalizados por COVID-19 antes y después de la introducción de las vacunas contra SARS-CoV-2 | |
| dc.type | artículo | |
| dc.volumen | 40 | |
| sipa.codpersvinculados | 64027 | |
| sipa.codpersvinculados | 3935 | |
| sipa.codpersvinculados | 163741 | |
| sipa.index | Scopus | |
| sipa.trazabilidad | Carga WOS-SCOPUS;01-05-2025 |
